Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00068224 · ClinicalTrials.gov registry record
Clinical and Molecular Investigations Into Ciliopathies
A clinical trial, sponsored by National Human Genome Research Institute (NHGRI).
- Completed
- Registry status
- 374
- Enrollment target
NCT00068224 is a clinical trial that has completed, run by National Human Genome Research Institute (NHGRI). The registered enrollment target is 374 participants.
The verdict
NCT00068224 has completed, sponsored by National Human Genome Research Institute (NHGRI).
- COMPLETED
- Registry status
- 374 participants
- Enrollment target
Study Summary
This study will evaluate patients ciliopathies. People with ciliopathies develop fibrocystic disease of the kidneys and liver, retinal degeneration, obesity, structural and functional defects of the central nervous system and the eyes, abnormal bone growth, abnormal sidedness of internal organs and polydactyly. The goal of the study is to better understand the medical complications of these disorders and identify characteristics that can help in the design of new treatments.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 374 participants |
| Start Date | 2003-03-16 |
| Est. Completion | 2021-02-18 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00068224
The ClinicalTrials.gov registry entry for NCT00068224 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 374 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is National Human Genome Research Institute (NHGRI), which has 185 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT00068224 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00068224 about?
NCT00068224 is a clinical study titled "Clinical and Molecular Investigations Into Ciliopathies". This study will evaluate patients ciliopathies. People with ciliopathies develop fibrocystic disease of the kidneys and liver, retinal degeneration, obesity, structural and functional defects of the central nervous system and the eyes, abnormal bone growth, abnormal sidedness of internal organs and ...
What is the current status of trial NCT00068224?
This trial is currently completed. The enrollment target is 374 participants. The study started on 2003-03-16. Estimated completion is 2021-02-18.
Who is sponsoring clinical trial NCT00068224?
This trial is sponsored by National Human Genome Research Institute (NHGRI), which has 185 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.